Our non-negotiable, no-compromise approach to Quality, is we believe the reason for the enduring trust and respect we have gained from our customers and partners across the globe.
Sri Krishna Pharmaceuticals strives for market leadership by supplying quality products consistently to the full satisfaction of its customers in national and global markets with a commitment to compliance of its products with regulatory and customer requirements. See below for a list of our API and FDF accreditations.
| API Country / Certification Accreditations | FDF Country / Certification Accreditations |
|---|---|
| USA (US FDA) | Mexico (COFEPRIS) |
| World Health Organization (WHO) | Thailand (FDA) |
| Europe (EDQM) | Canada (Health Canada) |
| Malta (Malta Medicines Authority) | |
| Ethiopia (EFDA) | |
| United Arab Emirates (MOHAP) | |
| Australia (TGA) | |
| Peru (DIGEMID) | |
| Philippines (FDA) | |
| Sweden (Läkemedelsverket) | |
| United Kingdom (MHRA) | |
| World Health Organization (WHO) |
The following products are covered under CEP/ COS from EDQM
- Acetaminophen (Paracetamol)
- Domperidone
- Domperidone Maleate
- Folic Acid
- Enalapril Maleate
- Furosemide
- Glibenclamide